AI-Assisted Reporting in Respiratory Labs: Where the Technology Is Heading and What It Means for Scientists in 2026
AI-assisted reporting is actively reshaping how respiratory labs operate. In 2026, artificial intelligence is no longer a future concept in clinical physiology - it is embedded in the daily workflow of scientists interpreting pulmonary function tests, generating reports, and managing patient documentation. The shift is significant: AI handles the repetitive, structured parts of reporting so scientists can focus on clinical judgment and patient outcomes.
TL;DR
AI is already embedded in respiratory lab workflows in 2026, from report generation to early detection of respiratory conditions.
Research highlights AI's growing role in monitoring, prediction, and patient engagement across pulmonary care.
The regulatory landscape for AI medical devices is maturing, with 950+ FDA-cleared AI devices and frameworks like the EU AI Act now in force.
Pulmonary function test software with built-in AI reporting tools reduces clinical risk by eliminating manual data entry and standardising outputs.
Rezibase integrates AI medical dictation software and ATS-aligned algorithms to support scientists and clinicians without replacing their expertise.
About the Author: This article is written by the Rezibase team - respiratory scientists and healthcare technology specialists with over 37 years of combined experience building software specifically for respiratory and sleep labs across Australia, New Zealand, the UK, and Ireland.
What Is AI-Assisted Reporting in the Context of Respiratory Labs?
AI-assisted reporting refers to the use of machine learning, natural language processing (NLP), and automated algorithms to help generate, structure, and quality-check clinical reports - in this case, specifically for respiratory and sleep investigations.
In a respiratory lab context, this means:
Automated data extraction from device outputs (spirometry, DLCO, body plethysmography, sleep studies)
AI-generated report drafts based on structured patient data and test results
NLP-powered dictation tools that convert clinician speech into structured, standards-aligned documentation
Algorithm-driven interpretation that flags results against guideline thresholds, such as ATS criteria
This is not about replacing scientists. It is about eliminating the cognitive load of formatting, cross-referencing normal values, and transcribing results manually.
What Does the Research Say About AI in Respiratory Care?
Research into AI's role in respiratory medicine has grown substantially. A 2024 study published in PMC found that AI algorithms have demonstrated the ability to detect respiratory conditions at an early stage, leading to timely interventions and improved patient outcomes [1]. That is a meaningful finding for labs, where early and accurate interpretation directly influences treatment pathways.
A 2026 scoping review published in npj Primary Care Respiratory Medicine found that AI is helping to shorten weaning from mechanical ventilation and is guiding closed-loop strategies for acute respiratory care [2]. The same review highlighted AI's expanding role in monitoring and prediction - areas that feed directly into what labs document and report.
On the patient-facing side, a 2024 article in Frontiers in Respiratory Care noted that AI-powered virtual assistants and chatbots are revolutionising patient engagement in pulmonary rehabilitation, using NLP to personalise communication [3]. While this is distinct from lab reporting, it signals how broadly NLP is being applied across the respiratory care continuum.
The takeaway from existing research is consistent: AI in respiratory care is not speculative. It is being studied, validated, and implemented across multiple touchpoints - and reporting is one of the most immediate and practical applications.
How Is the Regulatory Landscape Shaping AI in Clinical Labs?
Regulation is catching up to the technology, and scientists need to understand this context.
As of 2026, more than 950 AI-enabled medical devices have received FDA clearance, and the EU AI Act has introduced new compliance requirements for AI tools used in clinical settings [5]. Separately, a November 2025 analysis highlighted the urgent need for health technology assessment frameworks to keep pace with AI adoption, calling for structural changes, shared language, and public-private collaboration [4].
What this means practically for respiratory labs:
Regulatory Development | Implication for Labs |
|---|---|
950+ FDA-cleared AI devices | More validated tools available for clinical use |
EU AI Act | Software vendors must demonstrate transparency and risk classification |
Health Technology Assessment frameworks | Labs may need to document how AI tools are evaluated and governed |
The key point: choosing pulmonary function test software with AI features is not just a workflow decision - it is increasingly a governance and compliance decision. Labs should ask whether the software they use can demonstrate alignment with evolving standards.
What Are the Practical AI Features That Matter Most to Scientists Right Now?
Not all AI features deliver equal value in a lab setting. Based on where technology is heading, these are the capabilities with the most immediate impact:
AI medical dictation software integrated into the reporting workflow. Rather than transcribing separately and pasting into a report, clinicians dictate directly within the reporting environment, and AI structures the output in real time.
Automated report structuring aligned to clinical guidelines. AI that checks whether a report addresses ATS-required elements removes a significant quality-assurance burden.
Discrete data extraction from device imports. When pulmonary function test software can pull structured data directly from machine outputs - including flow-volume loops - scientists avoid the errors that come with manual re-entry.
Normal values cross-referencing. AI can flag when results fall outside expected ranges based on an up-to-date library of reference values, making interpretation faster and more defensible.
These are not futuristic features. They are the baseline of what modern respiratory reporting platforms should offer in 2026.
What Does This Mean for Scientists in Practice?
The honest answer is that AI changes the nature of the scientist's role rather than reducing it. The interpretive, clinical judgment component remains irreplaceable. What changes is where scientists spend their time.
With AI handling data extraction, report structuring, and normal value cross-referencing, scientists can:
Spend more time on complex cases that require genuine clinical reasoning
Reduce transcription errors that create downstream clinical risk
Produce consistent, guideline-aligned documentation across the team
Handle higher patient volumes without sacrificing report quality
Rezibase was built with exactly this philosophy. Its AI-powered report writing tools and ATS-aligned algorithms are integrated directly into the reporting workflow - not bolted on as an afterthought. The platform's Magic Import function automatically extracts discrete data from device reports, including flow-volume loops, eliminating double entry at the source.
For doctors reviewing reports, Rezibase includes AI medical dictation software built into the interface, a structured list of pending reports, and intelligent formatting that keeps documentation consistent and standards-aligned.
Frequently Asked Questions
Is AI in respiratory lab reporting accurate enough to trust clinically?
Current research supports AI's role as a support tool, not a standalone decision-maker. AI in reporting assists with structure, data extraction, and flagging - clinical interpretation remains the scientist's responsibility.
Does AI medical dictation software work within existing lab systems?
It depends on the platform. Purpose-built pulmonary function test software like Rezibase integrates dictation and AI structuring natively, which avoids the compatibility issues of third-party bolt-ons.
What standards should AI reporting tools align to?
ATS guidelines are the primary benchmark for respiratory reporting. Any AI reporting tool used in a clinical lab should be configurable to these standards.
How does AI affect accreditation requirements like TSANZ/NATA?
AI tools can support accreditation by improving documentation consistency and reducing non-conformance risk. Platforms that include dedicated accreditation modules make this more straightforward.
Will AI replace respiratory scientists?
No credible research or clinical consensus supports this. AI is consistently framed as a tool to improve efficiency and accuracy, not to substitute clinical expertise.
About Rezibase
Rezibase is Australia's most advanced cloud-based respiratory and sleep reporting platform, trusted by over 35 sites including NHS facilities in the UK and NSW Health in Australia. Built by respiratory scientists Peter Rochford and the late Jeff Pretto, and expanded under Cardiobase, the platform covers the full lifecycle of respiratory and sleep lab management - from referrals and bookings through to AI-assisted reporting, accreditation, and billing. Rezibase is manufacturer-agnostic, fully cloud-based, and backed by 37 years of experience in the field.
Curious about how AI-assisted reporting could work in your lab? Explore what Rezibase offers at rezibase.com.
References
Artificial intelligence in respiratory care: Current scenario and future perspective - PMC (pmc.ncbi.nlm.nih.gov)
The rise of artificial intelligence in respiratory primary care and pulmonology: a scoping review | npj Primary Care Respiratory Medicine (www.nature.com)
Frontiers | Artificial intelligence in respiratory care (www.frontiersin.org)
The urgent need for health technology assessment in the AI era (diagnostics.roche.com)
AI Medical Devices: 2025 Status, Regulation & Challenges | IntuitionLabs (intuitionlabs.ai)